video

Dyadic (DYAI) Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ

JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange...
Biotech Stock Review

Adding Immunomedics (IMMU) $3.00 to Watch List.

Biotech Stock Review Initiates Coverage. Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
video

HCN: The Most Exciting Internet Powered Network We’ve Seen Launched in Decades.

Is Privately Held Hotel Communications Network Following the Footsteps of FaceBook (FB)?. (Secret: Where Facebook started on a college...
coronavirus, biotech stock review

VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).

Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop...
Citius Pharma

Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.

STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...

Two Biotech Stocks on Takeover List?

Why These 2 Biotech Stocks Might Be Next On The Takeover List (IBD). Acadia Pharmaceuticals (ACAD) and Neurocrine Biosciences (NBIX) stand...
biotech stock review, dyadic

Must Watch Video: Dyadic’s (DYAI) Matthew Jones.

Click here to watch the video. It's the proverbial, "everything you wanted to know" about Cho...

Okay, so What’s Next for Citius Pharma (CTXR) $1.16?

Dawson James Broker/Dealer Updates. Price Target Remains at $7.00. "OK, So what’s Next? Topline data from the superior efficacy...

Crazy Valuations at Lyft? $20 Billion for $2 Billion in Rev’s (Quartz).

Lyft warns it may never make any money. “We have a history of net losses and we may...

HCN Network. Like Investing in Uber or Lyft, When They Only had 9,000 Drivers?

Internet Stock Review Report on Hotel Communications Network. HCN Communication Network has the most exciting Internet Advertising...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...